November 21, 2007 - Bayer HealthCare Pharmaceuticals Inc. has signed a three-year contract by MedAssets Supply Chain Systems, a group purchasing organization, to provide Magnevist (gadopentetate dimeglumine) Injection contrast media to members of the MedAssets network.
MedAssets serves more than 125 health systems, including 2,500 hospitals and 30,000 non-acute care healthcare providers. With this agreement, Magnevist is now on contract or has agreements with nearly all of the major GPOs in the United States.
The agreement is effective November 1, 2007, and includes 5, 10, 15 and 20 mL single-dose vials, 50 and 100 mL pharmacy bulk packages, and 10, 15 and 20 mL pre-filled syringes of Magnevist.
For more information: www.imaging.bayerhealthcare.com
July 09, 2024 
